Neonatal lung disease

Neonatal lung disease is most common in premature babies preferably before the 3rd trimester because of lack of surfactant produced cause problem in expanding of lungs. Some of the lung disease that affects the neonatal is bronchopulmonary dysplasia, Childhood interstitial lung disease, Meconium aspiration syndrome, and pneumonia. Surfactant replacement therapy is used in infants to cure respiratory distress syndrome. Lung diseases are most common in the neonates. Patent ductus arteriosus is the major cause for toxicity and death in premature babies. Respiratory syncytial virus is most common viral lung infection in both infants and premature infants. Wide knowledge on pathophysiology of lung disease and better understanding allowed developing more effective safe therapies for active and chronic disease. Pneumonia is the major cause of death in children in the developing countries.

 

  • Pulmonary hyperplasia
  • Pulmonary interstitial emphysema
  • Infant respiratory distress syndrome
  • Gene mutation
  • Chest radiography

Related Conference of Neonatal lung disease

June 09-10, 2020

10th European Epidemiology and Public Health Congress

Istanbul, Turkey
July 22-23, 2020

10th World Congress on Rare Diseases and Orphan Drugs

Barcelona, Spain
August 19-20, 2020

European Summit on HIV, STD and STIs

Milan, Italy
September 28-29, 2020

13th Global Infections Conference

Singapore
October 5-6, 2020

12th Euro-Global Conference on Infectious Diseases

Vienna, Austria
November 05-06, 2020

9th Asia Pacific STD and Infectious Diseases Congress

Tokyo, Japan
February 15-16, 2021

8th International Congress on Infectious Diseases

London, UK
February 22-23, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore

Neonatal lung disease Conference Speakers

Recommended Sessions

Related Journals

Are you interested in